| Literature DB >> 24217066 |
Fatih Altunkas1, Fatih Koc, Koksal Ceyhan, Atac Celik, Hasan Kadi, Metin Karayakali, Kerem Ozbek, Turgay Burucu, Ahmet Ozturk, Orhan Onalan.
Abstract
OBJECTIVE: To evaluate left and right ventricular functions using tissue Doppler echocardiography (TDE) and myocardial performance index (MPI) methods in patients with slow coronary flow (SCF) and to determine the relationship between these parameters and thrombolysis in myocardial infarction frame count in SCF patients. SUBJECTS AND METHODS: Thirty-five patients (20 males and 15 females) with SCF who underwent coronary angiography and 35 age- and sex-matched controls (14 males and 21 females) without SCF who underwent elective coronary angiography were enrolled in the study. Left ventricular (LV) and right ventricular (RV) functions were examined using conventional echocardiography and TDE.Entities:
Mesh:
Year: 2013 PMID: 24217066 PMCID: PMC5586939 DOI: 10.1159/000355471
Source DB: PubMed Journal: Med Princ Pract ISSN: 1011-7571 Impact factor: 1.927
Fig. 1Assessment of TFC value of the control group. a The first frame count of the LAD: the first frame used for TIMI frame counting is the first frame in which the dye fully enters the artery (arrow). b The last frame count of the LAD: the last frame is defined as the frame when the dye first enters the distal bifurcation of the LAD (arrow). TFC for this case was calculated as 20.
Fig. 2Assessment of TFC value in a patient with SCF. a The first frame count of the LAD: the first frame used for TIMI frame counting is the first frame in which the dye fully enters the artery (arrow). b The last frame count of the LAD: the last frame is defined as the frame when the dye first enters the distal bifurcation of the LAD (arrow). TFC for this case was calculated as 90.
Fig. 3RV tissue Doppler velocities. Assessment of RV Doppler velocities in the control (a) and SCF (b) groups. ICT = Isovolumetric contraction time.
Demographic and angiographic characteristics in the SCF and control groups
| SCF (n = 35) | Controls (n = 35) | p | |
|---|---|---|---|
| Age, years | 55 ± 11 | 54 ± 9 | 0.79 |
| Male sex | 20 (57) | 14 (40) | 0.15 |
| Body mass index | 31 ± 4 | 30 ± 4 | 0.17 |
| Systolic blood pressure, mm Hg | 126 ± 19 | 124 ± 22 | 0.65 |
| Diastolic blood pressure, mm Hg | 80 ± 12 | 77 ± 12 | 0.29 |
| Hypertension | 19 (54) | 14 (40) | 0.23 |
| Hyperlipidemia | 18 (51) | 12 (34) | 0.15 |
| Diabetes mellitus | 5 (14) | 9 (26) | 0.23 |
| Smoking | 6 (17) | 7 (20) | 0.76 |
| Family history | 7 (20) | 4 (11) | 0.32 |
| Medications | |||
| ACEI/ARB | 14 (40) | 10 (29) | 0.31 |
| β-Blockers | 10 (29) | 9 (26) | 0.79 |
| Nitrates | 6 (17) | 3 (9) | 0.48 |
| Calcium antagonists | 2 (6) | 4 (11) | 0.67 |
| Statin | 11 (31) | 6 (17) | 0.16 |
| Fasting serum glucose, mg/dl | 102 ± 23 | 105 ± 17 | 0.3 |
| Creatinin, mg/dl | 0.74 ± 0.18 | 0.72 ± 0.17 | 0.59 |
| Total cholesterol, mg/dl | 204 ± 43 | 202 ± 43 | 0.824 |
| Triglycerides, mg/dl | 176 ± 141 | 168 ± 82 | 0.49 |
| HDL cholesterol, mg/dl | 43 ± 12 | 43 ± 11 | 0.803 |
| LDL cholesterol, mg/dl | 124 ± 31 | 129 ± 34 | 0.53 |
| Vessels with slow flow | |||
| One vessel | 5 (14) | 0 (0) | 0.05 |
| Two vessels | 14 (40) | 0 (0) | <0.001 |
| Three vessels | 16 (46) | 0 (0) | <0.001 |
| TFC | |||
| LAD | 59 ± 19 | 34 ± 3 | <0.001 |
| Cx | 30 ± 10 | 22 ± 2 | <0.001 |
| RCA | 30 ± 9 | 20 ± 2 | <0.001 |
| cLAD | 35 ± 11 | 20 ± 2 | <0.001 |
| Mean | 32 ± 10 | 21 ± 2 | <0.001 |
Values are means ± SD or numbers with percentages in parentheses. ACEI = Angiotensin-converting enzyme inhibitor; ARB = angiotensin II receptor blocker; LDL = low-density lipoprotein; HDL = high-density lipoprotein.
Two-dimensional M-mode and PWD echocardiography in the SCF and control groups
| SCF (n = 35) | Controls (n = 35) | p | |
|---|---|---|---|
| LVEDD, cm | 5 ± 0.6 | 4.8 ± 0.4 | 0.17 |
| LVESD, cm | 3.3 ± 0.8 | 3 ± 0.4 | 0.12 |
| IVS, cm | 1.1 ± 0.2 | 1 ± 0.2 | 0.86 |
| EF, % | 59.6 ± 1.4 | 59.7 ± 1.4 | 0.87 |
| PW, cm | 1 ± 0.2 | 0.9 ± 0.1 | 0.23 |
| RVEDD, cm | 3.2 ± 0.6 | 3.2 ± 0.4 | 0.91 |
| RVESD, cm | 2.2 ± 0.6 | 2.1 ± 0.3 | 0.15 |
| LA, cm | 3.6 ± 0.7 | 3.5 ± 0.4 | 0.43 |
| LV mass, g | 223 ± 63 | 202 ± 55 | 0.28 |
| E, cm/s | 65 ± 16 | 69 ± 20 | 0.41 |
| A, cm/s | 73 ± 19 | 80 ± 26 | 0.3 |
| DT, ms | 200 ± 43 | 201 ± 42 | 0.95 |
| E/A | 0.95 ± 0.33 | 0.91 ± 0.32 | 0.58 |
| E/Em | 9.5 ± 2.4 | 10.1 ± 4.2 | 0.45 |
| Ps/Pd | 1.29 ± 0.3 | 1.27 ± 0.31 | 0.75 |
| Ra, cm/s | 25 ± 4 | 26 ± 6 | 0.7 |
Values are means ± SD. LVEDD = Left ventricular end-diastolic diameter; LVESD = left ventricular end-systolic diameter; IVS = interventricular septum; EF = ejection fraction; PW = posterior wall; RVEDD = right ventricular end-diastolic diameter; RVESD = right ventricular end-systolic diameter; LA = left atrial diameter; DT = deceleration time of the mitral valve; Ra = pulmonary venous atrial reversal wave.
Tissue Doppler imaging measurements in the SCF and control groups
| SCF (n = 35) | Controls (n = 35) | p | |
|---|---|---|---|
| Left ventricle | |||
| Sm, cm/s | 8.2 ± 1.3 | 7.9 ± 1.3 | 0.39 |
| Em, cm/s | 7.1 ± 1.9 | 7.3 ± 2 | 0.73 |
| Am, cm/s | 11 ± 2.2 | 10.2 ± 1.7 | 0.13 |
| Em/Am | 0.69 ± 0.31 | 0.73 ± 0.23 | 0.53 |
| IRT, ms | 99 ± 17 | 88 ± 20 | 0.01 |
| MPI | 0.61 ± 0.11 | 0.56 ± 0.12 | 0.07 |
| Right ventricle | |||
| Sm, cm/s | 13.5 ± 2.6 | 12.4 ± 2.5 | 0.08 |
| Em, cm/s | 9.8 ± 3.1 | 9.3 ± 2.6 | 0.54 |
| Am, cm/s | 13.9 ± 3 | 17.2 ± 19 | 0.42 |
| IRT, ms | 83 ± 28 | 74 ± 29 | 0.21 |
| MPI | 0.52 ± 0.17 | 0.51 ± 0.18 | 0.93 |
Values are means ± SD.